Tuberculosis (TB) is increasing world wide. The effect of AIDS in combination with TB is to increase the risk of illness by 14%. AIDS also makes diagnosis more difficult, because of its depressing effect on host resistance and by reducing the value of the tuberculin test. The development of multiple drug resistance (MDR-R) -to isoniazid and rifampicin (MDR-TB) -increases the rate of spread. Resistance is encouraged by inadequate and inconsistent therapy. Traditionally, patient home management treatment has been the norm, but inconsistent administration and erroneous dosage increases the risks of MDR-R and fuels the spread of TB. The directly observed short course treatment (DOTS) has shown marked improvements in curing the disease and in reducing the spread of MDR-R.
Although TB is generally an adult disease, children form a reservoir from which the organism can spread into the general population. In many countries, the population do not have an understanding of TB; that it can be cured providing treatment is administered properly. With declining health budgets and lack of free government medical care, ill people tend to go first to private clinics, where diagnoses are often uncontrolled, leading to inappropriate medication. Diagnosis is especially difficult in children: the tuberculin test may be falsely negative due to the immunodepressive effect of malnutrition and the use of a systematic clinical scoring system, as described in this issue (see van Beekhuizen p. 155), has great importance. In the absence of specific tests, clinical factors become more important. The Tuberculosis Score Chart attempts to codify clinical findings to sharpen the diagnosis. In this study, the authors were able to define a score, above which there was a very high risk of TB, with a low rate of false positives. Thus, treatment could be started immediately.
While this first study is valuable, the method should be tried out in other areas, to account for local variations in clinical presentations. Diagnosis and treatment by itself is not enough. Mass education of the population on the nature and treatment of TB and the routine use of DOTS would assist in turning back this world-wide epidemic. Such clinical methods should be validated by the more specific laboratory tests. Polymerase chain reaction, DNA amplification, and a number of antigen tests have been demonstrated. These would be valuable adjuncts to validate clinical diagnoses. The use of culture of gastric washings can be refined by attention to the details of collection, timing, base neutralization and rapid processing of samples. It is hoped that National Tuberculosis Reference Laboratories will develop methods which can be used in the field. These improvements are vitally necessary as MDR-R is increasing fastest in those countries where treatment is erratic and the combination with AIDS is rapidly producing epidemics in certain countries.
